[go: up one dir, main page]

AR080387A1 - Compuestos arilvinilazacicloalcano para la constipacion - Google Patents

Compuestos arilvinilazacicloalcano para la constipacion

Info

Publication number
AR080387A1
AR080387A1 ARP110100718A ARP110100718A AR080387A1 AR 080387 A1 AR080387 A1 AR 080387A1 AR P110100718 A ARP110100718 A AR P110100718A AR P110100718 A ARP110100718 A AR P110100718A AR 080387 A1 AR080387 A1 AR 080387A1
Authority
AR
Argentina
Prior art keywords
constipation
arilvinilazacicloalcano
compounds
ylvinyl
pyrrolidin
Prior art date
Application number
ARP110100718A
Other languages
English (en)
Inventor
Steven M Toler
David A Hosford
Patrick M Lippiello
Geoffrey A Dunbar
William Scott Caldwell
Parviz Hamedni
Merouane Bencherif
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Publication of AR080387A1 publication Critical patent/AR080387A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Métodos para tratar la constipacion y mejorar la motilidad del colon mediante la administracion de 5-((E)-2-pirrolidin-3-ilvinil)pirimidina o una sal farmacéuticamente aceptable de ella.
ARP110100718A 2010-03-11 2011-03-09 Compuestos arilvinilazacicloalcano para la constipacion AR080387A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31294410P 2010-03-11 2010-03-11

Publications (1)

Publication Number Publication Date
AR080387A1 true AR080387A1 (es) 2012-04-04

Family

ID=44564064

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100718A AR080387A1 (es) 2010-03-11 2011-03-09 Compuestos arilvinilazacicloalcano para la constipacion

Country Status (11)

Country Link
US (1) US20130237550A1 (es)
EP (1) EP2544690A4 (es)
JP (1) JP2013522201A (es)
CN (1) CN102858342B (es)
AR (1) AR080387A1 (es)
AU (1) AU2011224697A1 (es)
CA (1) CA2792157A1 (es)
MX (1) MX2012010491A (es)
TW (1) TW201138778A (es)
UY (1) UY33266A (es)
WO (1) WO2011112428A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10933240B2 (en) * 2018-02-12 2021-03-02 The Feinstein Institutes For Medical Research Treatment of inflammation by selective DMV cholinergic neuron stimulation
WO2023150169A1 (en) * 2022-02-01 2023-08-10 University Of Maryland, Baltimore Ionizable polyesters, polyplexes and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629325A (en) * 1996-06-06 1997-05-13 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
EP1212319A2 (en) * 1999-09-14 2002-06-12 Abbott Laboratories 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
CN1473156A (zh) * 2000-11-10 2004-02-04 - 嘧啶衍生物及其作为神经肽y受体配体的用途
US7098331B2 (en) * 2003-03-05 2006-08-29 Targacept, Inc. Arylvinylazacycloalkane compounds and methods of preparation and use thereof
WO2008157365A2 (en) * 2007-06-15 2008-12-24 Targacept, Inc. Vinylazacycloalkanes for treating neuropathic pain
CA3090738C (en) * 2008-12-01 2023-06-13 Oyster Point Pharma, Inc. Synthesis and salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine

Also Published As

Publication number Publication date
MX2012010491A (es) 2013-01-25
EP2544690A2 (en) 2013-01-16
JP2013522201A (ja) 2013-06-13
US20130237550A1 (en) 2013-09-12
AU2011224697A1 (en) 2012-10-04
EP2544690A4 (en) 2013-07-10
CA2792157A1 (en) 2011-09-15
WO2011112428A3 (en) 2012-01-05
CN102858342B (zh) 2014-12-10
CN102858342A (zh) 2013-01-02
TW201138778A (en) 2011-11-16
WO2011112428A2 (en) 2011-09-15
UY33266A (es) 2012-09-28

Similar Documents

Publication Publication Date Title
GT201200164A (es) "nuevos compuestos de espiropiperidina"
CO6531458A2 (es) Nuevos compuestos de espiropiperidina
CR20150416A (es) Inhibidores de cdc7
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
UA109464C2 (uk) Спірооксіндольні антагоністи mdm2
EA201591296A1 (ru) Фталазиноны и изохинолиноны в качестве ингибиторов rock
EA201391615A1 (ru) Дейтерированные потенциаторы cftr
PH12016500164B1 (en) Therapeutically active compounds and their methods of use
CR20130598A (es) Composiciones de nucleasa terapéuticas y métodos
TN2014000210A1 (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
EA201490944A1 (ru) Двойной ингибитор met и vegf для лечения рака
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
DK2709453T3 (da) Anvendelse af thiazolid-forbindelser til forebyggelse og behandling af virussygdomme, cancer og sygdomme forårsaget af intracellulære infektioner
UY32153A (es) Inhibidores de piridomidinona de pi13ka(alfa) y mtor
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
AR088297A1 (es) R(+)-n-formil-propargil-aminoindano
MX349254B (es) Compuestos para el tratamiento del sindrome metabolico.
ECSP12012354A (es) Compuestos heterocíclicos, su preparación y su aplicación terapéutica
DK2819516T3 (da) Anvendelse af (1r,5s)-(+)-1-(naphthalen-2-yl)-3-azabicyclo{3.1.0}hexan i behandlingen af lidelser forbundet med monoamin-neurotransmittere
EA201590656A1 (ru) Азаиндолины
AR080387A1 (es) Compuestos arilvinilazacicloalcano para la constipacion
ES2571452T3 (es) Compuesto antagonista de leucotrieno B4
UY33939A (es) Inhibidores de la péptido desformilasa
AR099416A1 (es) Terapia combinada para la hipertensión resistente
AR092627A1 (es) Derivados glucopiranosidos de urea

Legal Events

Date Code Title Description
FB Suspension of granting procedure